Sanofi India Q2 FY25: ₹70 Cr Profit – Premium Drugmaker, Generic Growth
August 1, 2025
No Comments
At a Glance Sanofi India, the pharma aristocrat with French roots and Indian execution, has turned in a Q2 FY25
At a Glance Sanofi India, the pharma aristocrat with French roots and Indian execution, has turned in a Q2 FY25
At a Glance Swojas Foods, a tiny agri-food company, just pulled a “Bollywood twist” – Q1 FY26 profits jumped 1200%
At a Glance 3i Infotech, the IT service survivor that refuses to die, just posted a ₹7.55 crore profit in
At a Glance Accelya Solutions, the quiet airline IT whisperer, just served Q1 FY26 numbers with an EPS of ₹22.75
At a Glance PDS Ltd stitched a 14% revenue growth this quarter, but the fashion police (read: investors) are screaming
At a Glance Chalet Hotels just dropped a Q1 FY26 bombshell: revenue skyrocketed 146% to ₹895 crore while PAT went
Disclaimer – EduInvesting is a financial entertainment and commentary platform. The content you read is for informational and educational purposes only. It is not financial advice, not a research report, and not a buy/sell recommendation.
We’re not SEBI-registered advisors. We’re just funny people with WiFi. Please consult an actual financial expert before making decisions — preferably one that charges more than chai prices.
© 2025 EduInvesting.in — All rights reserved.
Finance news, Market sarcasm and stock market commentay delivered daily with zero jargon and maximum masala.
Built by humans. Powered by chai. Inspired by your FOMO.